- Home
- ALBT vs WLGS Comparison
ALBT vs WLGS Comparison
Compare ALBT & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- WLGS
- Stock Information
- Founded
- ALBT 2014
- WLGS 1981
- Country
- ALBT United States
- WLGS Hong Kong
- Employees
- ALBT N/A
- WLGS N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- WLGS Engineering & Construction
- Sector
- ALBT Health Care
- WLGS Consumer Discretionary
- Exchange
- ALBT Nasdaq
- WLGS Nasdaq
- Market Cap
- ALBT 2.9M
- WLGS 22.2M
- IPO Year
- ALBT N/A
- WLGS 2023
- Fundamental
- Price
- ALBT $0.20
- WLGS $2.48
- Analyst Decision
- ALBT
- WLGS
- Analyst Count
- ALBT 0
- WLGS 0
- Target Price
- ALBT N/A
- WLGS N/A
- AVG Volume (30 Days)
- ALBT 633.7K
- WLGS 254.3K
- Earning Date
- ALBT 11-12-2024
- WLGS 11-01-2024
- Dividend Yield
- ALBT N/A
- WLGS N/A
- EPS Growth
- ALBT N/A
- WLGS N/A
- EPS
- ALBT N/A
- WLGS N/A
- Revenue
- ALBT N/A
- WLGS $6,825,879.00
- Revenue This Year
- ALBT N/A
- WLGS N/A
- Revenue Next Year
- ALBT N/A
- WLGS N/A
- P/E Ratio
- ALBT N/A
- WLGS N/A
- Revenue Growth
- ALBT N/A
- WLGS 63.69
- 52 Week Low
- ALBT $0.16
- WLGS $0.40
- 52 Week High
- ALBT $1.44
- WLGS $4.20
- Technical
- Relative Strength Index (RSI)
- ALBT 43.14
- WLGS 61.00
- Support Level
- ALBT $0.16
- WLGS $2.33
- Resistance Level
- ALBT $0.22
- WLGS $4.20
- Average True Range (ATR)
- ALBT 0.03
- WLGS 0.64
- MACD
- ALBT 0.00
- WLGS 0.07
- Stochastic Oscillator
- ALBT 27.54
- WLGS 38.57
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.